Rheumatoid arthritis patients run an increased risk of malignant cancers, independent of biologic and DMARD treatment, researchers report.
Mayo Clinic's Timothy Niewold, M.D., speaks with Rheumatology Network about the latest innovations in personalized medicine for rheumatoid arthritis. Scientific advances point to the role of environmental triggers and risk genes.
In this Q&A, Dr. Saag discusses the status of prednisone to treat rheumatoid arthritis, new treatments for osteoporosis and more.
Chronic consumption of sugar-sweetened beverages leads to increased BMI and gout risk, study shows.